The effectiveness of hyaluronic acid in reducing adverse effects associated with inhaled hypertonic saline therapy in patients with cystic fibrosis: A systematic review and meta-analysis
# Background Inhaled hypertonic saline (HS) is an effective mucolytic agent in patients with cystic fibrosis (CF). However, adverse events can impair the clinical utility of hypertonic saline (HS) in this patient population. In this study, we aimed to investigate the effectiveness of hyaluronic aci...
Saved in:
Main Authors: | Sana Arshid, Saad Ehsan Ullah, Junaid Imran, Meeran Asher Syed, Aakash Choradia, Nicole Gousy, Sukhman Boparai, Mudassir Shoaib, Bidhan Bikram Shah, Aadarsh Netha |
---|---|
Format: | Article |
Language: | English |
Published: |
Canadian Society of Respiratory Therapists
2023-10-01
|
Series: | Canadian Journal of Respiratory Therapy |
Online Access: | https://doi.org/10.29390/001c.89093 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Median Preoptic Nucleus Mediates the Cardiovascular Recovery Induced by Hypertonic Saline in Hemorrhagic Shock
by: Nathalia Oda Amaral, et al.
Published: (2014-01-01) -
Optimal Dose and Concentration of Hypertonic Saline in Traumatic Brain Injury: A Systematic Review
by: Martin SUSANTO, et al.
Published: (2022-06-01) -
Symptomatic Abdominal Simple Cysts: Is Percutaneous Sclerotherapy with Hypertonic Saline and Bleomycin a Treatment Option?
by: V. D. Souftas, et al.
Published: (2015-01-01) -
Adrenal Crisis Caused by Inhaled Fluticasone in an Adolescent with Cystic Fibrosis and Advanced Hepatopathy: A Case Report
by: C. Denne, et al.
Published: (2012-01-01) -
A Pilot Study to Compare Tobramycin 80 mg Injectable Preparation wth 300 mg Solution for Inhalation in Cystic Fibrosis Patients
by: Wilfried H Nikolaizik, et al.
Published: (2008-01-01)